Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALXO | AZN | AMGN | GILD | VRTX |
| Company | Alx Oncology Holdings Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.5200 | 70.25 | 280.63 | 103.86 | 495.40 |
| High | 0.5642 | 70.81 | 284.10 | 106.18 | 498.65 |
| Low | 0.5115 | 69.53 | 280.00 | 103.14 | 490.37 |
| Last | 0.5297 | 69.64 | 282.23 | 106.29 | 494.62 |
| Change | -0.0120 | +0.07 | +1.39 | +3.12 | +0.78 |
| % Change | -2.22% | +0.10% | +0.49% | +3.02% | +0.16% |
| Volume | 332,858 | 5,665,908 | 924,213 | 4,626,048 | 625,107 |
| 20-Day Average Volume | 553,105 | 6,848,270 | 3,194,246 | 9,666,418 | 1,678,696 |
| Previous Close | 0.5417 | 69.57 | 280.84 | 103.17 | 493.84 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5489 | 68.60 | 288.91 | 106.34 | 485.56 |
| 20-Day Raw Stochastic | 31.67% | 58.37% | 29.68% | 58.42% | 82.14% |
| 20-Day Relative Strength | 37.11% | 47.88% | 42.77% | 48.93% | 52.80% |
| Weighted Alpha | -93.24 | -9.68 | -11.17 | +58.29 | +19.36 |
| Today's Opinion | 100% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Previous Opinion | 100% Sell | 56% Sell | 56% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 16% Buy | 80% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.01% since 04/21/25 | +4.16% since 04/21/25 | +2.87% since 04/21/25 | +1.47% since 04/21/25 | +3.15% since 04/21/25 |
| Low | 0.5115 on 04/28/25 | 66.87 on 04/22/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 480.56 on 04/22/25 |
| High | 0.6600 on 04/23/25 | 70.81 on 04/28/25 | 284.10 on 04/28/25 | 107.56 on 04/24/25 | 498.65 on 04/28/25 |
| 1-Month | |||||
| %Chg | -19.63% since 03/28/25 | -5.57% since 03/28/25 | -8.28% since 03/28/25 | -5.30% since 03/28/25 | -0.03% since 03/28/25 |
| Low | 0.4600 on 04/10/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 0.6700 on 03/31/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 502.22 on 04/16/25 |
| 3-Month | |||||
| %Chg | -65.59% since 01/28/25 | +0.13% since 01/28/25 | +0.44% since 01/28/25 | +12.80% since 01/28/25 | +11.77% since 01/28/25 |
| Low | 0.4600 on 04/10/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 430.81 on 01/29/25 |
| High | 1.5100 on 01/29/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -63.94% since 10/28/24 | -8.33% since 10/28/24 | -11.24% since 10/28/24 | +19.27% since 10/28/24 | +3.40% since 10/28/24 |
| Low | 0.4600 on 04/10/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 2.0500 on 12/18/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 27,547 | 212,311,376 | 158,279,088 | 133,543,728 | 121,877,672 |
| Shares Outstanding, K | 53,396 | 3,101,247 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -134,850,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -29,160,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 1.20 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.55 on 03/06/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/08/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.93 | 14.17 | 13.33 | 0.00 |